---
schema_version: "secwatch.filing_event.v1"
accession: "0001159036-23-000014"
form_type: "8-K"
ticker: "HALO"
cik: "0001159036"
company_name: "HALOZYME THERAPEUTICS, INC."
filed_at: "2023-02-23T23:59:59+00:00"
generated_at: "2026-06-19T01:34:47.869540+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Director James M. Daly to resign from Halozyme board at end of 2023

## Summary
- James M. Daly notified Halozyme of his resignation from the Board, effective December 31, 2023.
- Resignation is not due to any disagreement with the Company, its operations, strategy, management, or Board.
- Mr. Daly's departure is planned nearly a year in advance, allowing for orderly succession.

## SEC filing metadata
- accession: 0001159036-23-000014
- form_type: 8-K
- ticker: HALO
- cik: 0001159036
- company_name: HALOZYME THERAPEUTICS, INC.
- filed_at: 2023-02-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1159036/000115903623000014/0001159036-23-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1159036/000115903623000014/halo-20230222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001159036-23-000014
- JSON: https://secwatch.observer/filing/0001159036-23-000014.json
- Plain text: https://secwatch.observer/filing/0001159036-23-000014.txt

## Key facts
- Executive change
  James M. Daly resigned as Director at HALOZYME THERAPEUTICS, INC..
  - Action: resigned
  - Role: Director
  source text: On February 22, 2023, James M. Daly, a member of the Board of Directors of Halozyme Therapeutics, Inc. (the “Company”), notified the Company of his intention to resign from the Company’s Board of Directors effective at the end of the 2023 calendar year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1159036/000115903623000014/0001159036-23-000014-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.